LO-MALMOREDE Drug Patent Profile
✉ Email this page to a colleague
When do Lo-malmorede patents expire, and when can generic versions of Lo-malmorede launch?
Lo-malmorede is a drug marketed by Novast Labs and is included in one NDA.
The generic ingredient in LO-MALMOREDE is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LO-MALMOREDE?
- What are the global sales for LO-MALMOREDE?
- What is Average Wholesale Price for LO-MALMOREDE?
Summary for LO-MALMOREDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| DailyMed Link: | LO-MALMOREDE at DailyMed |
US Patents and Regulatory Information for LO-MALMOREDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | LO-MALMOREDE | ethinyl estradiol; ethynodiol diacetate | TABLET;ORAL-28 | 209548-001 | Feb 11, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
